17 Aug Hydrochlorothiazide – Risk of non-menoloma skin cancer
Posted at 13:04h
in
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), the below listed companies would like to inform you of a new risk of non-melanoma skin cancer (NMSC) (basal cell carcinoma, squamous cell carcinoma) in patients treated with hydrochlorothiazide.
2019 Apr
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
10/04/2019
File Type:
pdf
Category:
Communication To Health Care Professionals